Composition
- Active ingredients
- CLOFAZIMINE 50MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CLOFAZIMINE 100MG · CapsuleNDA019500-001 · Discontinued
- CLOFAZIMINE 50MG · CapsuleThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA019500.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Lamprene
- Active substance
- clofazimine
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Novartis
- Status
- Discontinued
- FDA approval
- 15 Dec 1986
- Application
- NDA019500-002